share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bruno Julianne

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bruno Julianne

CRISPR Therapeutics | 4：持股變動聲明-高管 Bruno Julianne
美股sec公告 ·  06/25 05:36
牛牛AI助理已提取核心訊息
CRISPR Therapeutics COO Julianne Bruno sold 3,366 shares of the company's common stock on 06/21/2024, as per the latest SEC filings. The shares were sold at a price of $56.09 each, totaling approximately $188,798.94. This transaction followed an acquisition of 7,000 shares on 06/20/2024 through the exercise of derivative securities. After these transactions, Bruno directly holds 6,745 shares of CRISPR Therapeutics. Additionally, Bruno has an indirect beneficial ownership of 7,088 shares through The Julianne Bruno 2022 GRAT. The transactions have been reported as completed.
CRISPR Therapeutics COO Julianne Bruno sold 3,366 shares of the company's common stock on 06/21/2024, as per the latest SEC filings. The shares were sold at a price of $56.09 each, totaling approximately $188,798.94. This transaction followed an acquisition of 7,000 shares on 06/20/2024 through the exercise of derivative securities. After these transactions, Bruno directly holds 6,745 shares of CRISPR Therapeutics. Additionally, Bruno has an indirect beneficial ownership of 7,088 shares through The Julianne Bruno 2022 GRAT. The transactions have been reported as completed.
CRISPR Therapeutics的首席運營官Julianne Bruno根據最新的美國證監會申報文件於2024年06月21日出售了3366股公司普通股，每股價格爲56.09美元，總計約188,798.94美元。 這次交易是在通過衍生證券行使收購7000股股份的後續執行的。這些交易後，Bruno直接持有CRISPR Therapeutics 6745股。此外，Bruno通過The Julianne Bruno 2022 GRAT間接持有7088股股份。這些交易已經被報告爲已完成。
CRISPR Therapeutics的首席運營官Julianne Bruno根據最新的美國證監會申報文件於2024年06月21日出售了3366股公司普通股，每股價格爲56.09美元，總計約188,798.94美元。 這次交易是在通過衍生證券行使收購7000股股份的後續執行的。這些交易後，Bruno直接持有CRISPR Therapeutics 6745股。此外，Bruno通過The Julianne Bruno 2022 GRAT間接持有7088股股份。這些交易已經被報告爲已完成。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。